Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SERS-Based Serum Molecular Spectral Screening for Non-Small Cell Lung Cancer vs. Small Cell Lung Cancer: A Multicenter, Open-Label, Double-Blind, Independent Data Analysis Clinical Trial

NCT06775002 is registered in ClinicalTrials.gov with Fuzhou General Hospital as lead sponsor.

NCT NCT06775002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06775002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SERS-Based Serum Molecular Spectral Screening for Non-Small Cell Lung Cancer vs. Small Cell Lung Cancer: A Multicenter, Open-Label, Double-Blind, Independent Data Analysis Clinical Trial
Lead sponsor
Fuzhou General Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
April 5, 2026
Completion date
November 20, 2026
Enrollment
223 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer small cell lung cancer (sclc), lung cancer, non-small cell